ProRx Pharma, the leading health and wellness 503B outsourcing facility, today announced the availability of its innovative oral NAD+ formulation. This advancement introduces a new, convenient option for medical clinics and wellness providers seeking to support cellular energy, DNA repair, and long-term vitality in their patients without relying on daily injectable protocols.
Declining NAD+ (nicotinamide adenine dinucleotide) levels can contribute to fatigue, slower recovery, and cognitive decline, and NAD+ is essential for cellular energy, DNA repair, and longevity.[1] ProRx Pharma’s exclusive oral delivery system provides the traditional benefits of NAD+ without the burden of maintaining daily injection protocols. Through this liquid delivery system, each NAD+ dose provides reliable stability and consistency. Read More >
